Xeris Pharmaceuticals | Eiendeler



Assets Endring Dato
Adcock Ingram Holdings ZAR 8.35B 25.86M 2024-06
Celltrion KRW 20.31T 180.03B 2024-09
Cspc Pharmaceutical CNY 47.9B 1.61B 2024-06
Dianthus Therapeutics USD 354.25M 14.71M 2024-09
Ecofibre AUD 71.25M 1.95M 2024-06
Eli Lilly USD 78.71B 3.11B 2024-12
Kangmei Pharma CNY 14.19B 63.4M 2024-09
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Laboratorios Farma EUR 857.32M 78.66M 2024-06
Malin Corporation EUR 128.4M 11.8M 2024-06
Medical Developments International AUD 59.16M 31.9M 2024-06
Neuren Pharmaceuticals AUD 409.71M 181.55M 2024-12
Organigram Holdings CAD 479.21M 71.35M 2024-12
Pacira USD 1.55B 31.82M 2024-12
Perrigo USD 9.65B 1.56B 2024-12
Pharma Mar EUR 349.64M 16.52M 2024-12
Qiagen NV USD 5.69B 580.57M 2024-12
Sartorius EUR 9.79B 148.6M 2024-09
Sino Biopharmaceutical CNY 66.7B 3.1B 2024-06
Supernus Pharmaceuticals USD 1.37B 25.37M 2024-12
Tilray USD 4.19B 70.11M 2024-11
Zz Pientze Pharmaceu 17.99B 940.45M 2024-09



Xeris Pharmaceuticals Eiendeler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.